Safety and efficacy of contrast-enhanced MRI in the brain, head and neck: Gadodiamide injection versus gadopentate dimeglumine

Journal Belge de Radiologie

Volumn 80, Issue 5, 1997, Pages 225-228

  Sadni, M ^a   Collignon, J ^a   Dondelinger, R F ^a,c   De Greef, D ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Nycomed SA/NV   (Belgium)

^c CHU SART TILMAN   (Belgium)

Author keywords

Brain; Contrast agents; Head neck; Magnetic resonance IRM; MR

Indexed keywords

CODEINE; CONTRAST MEDIUM; GADODIAMIDE; GADOLINIUM PENTETATE; PARACETAMOL;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIPLOPIA; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEAD AND NECK DISEASE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BRAIN DISEASES; CEREBELLAR DISEASES; CONTRAST MEDIA; CRANIAL FOSSA, POSTERIOR; DIPLOPIA; DOUBLE-BLIND METHOD; FEMALE; GADOLINIUM DTPA; HEAD; HEADACHE; HUMANS; IMAGE ENHANCEMENT; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NECK; PITUITARY DISEASES; PRURITUS; SAFETY;

EID: 0030785372     PISSN: 00217646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Elster A.D., Moody D.M., Ball M.R., Laster D.W.: Is gadopentate dimeglumine required for routine cranial. MRI? Radiology, 1989, 173: 231-238.
2. Weinmann HJ., Brasch R.C., Press W.R., et al.: Characteristics of gadolinium-DTPA complex: a potentitial NMR contrast agent. AJR, 1984, 142: 619-624.
3. Van Wagoner M., O'Toole M., Leese P.T., et al.: A phase I clinical trial with gadodiamide injection, a nonionic magnetic resonance imaging enhancement agent. Invest Radiol, 1991, 26: 980-986.
4. Cacheris W.P., Quary S.C., Rocklage S.M.: The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imaging, 1990, 8: 467-481.
5. Sze G., Brant-Zawadzki M., Haughton V.M., et al.: Multicenter study of gadodiamide injection as a contrast agent in MRI of the brain and spine. Radiology, 1991, 181: 693-699.
6. Akeson P., Jonsson E., Haugen I., et al.: Contrast-enhanced MRI of the central nervous system: comparison betwen gadodiamide injection and gadolinium-DTPA. Neuroradiology, 1995, 37: 229-233.
7. Lundby B., Svaland M., Gordon P., et al.: Experience with gadodiamide injection in clinical phase III trials. Clinical MRI, 1995, 5: 103-107.
8. Chanalet S., Masson B., Boyer L., et al.: Etudes comparatives de la tolérance du gadodiamide, du gadopentétate de diméglumine et du gadotérate de méglumine au cours d'un examen IRM du système nerveux central. J Radiol, 1995, 76: 417-421.
9. Aslanian V., Lemaignen H., Bunouf P., et al.: Evaluation clinique de la tolérance du gadodiamide, nouvel agent de contraste non-ionique pour I'IRM du système nerveux central. J Radial, 1995, 76: 431-434.
10. Vogl T.J., Western A., Mack G., et al.: MR imaging of head and neck lesions using high-dose gadodiamide injection: a phase III clinical trial. Eur Radial, 1995, 5: 609-614.
11. Balériaux D., Matos C., De Greef D.: Gadodiamide injection as a contrast medium for MRI of the central nervous system: a comparison with gadolinium-DOTA. Neuroradiology, 1993, 35: 490-494.
12. Kaplan G.D., Aisen A.M., Aravavapalli S.R.: Preliminary clinical trial of gadodiamide injection: a new nonionic gadolinium contrast agent for MRI. JMRI, 1991, 1: 57-62.
13. Runge V.M., Bradley W.G., Brant-Zawadzki M.N., et al.: Clinical safety and efficacy of gadoteridol: a study in 411 patients with suspected intracranial and spinal disease. Radiology, 1991, 181: 701-709.
14. Carlvin M.J., Rajan S.S., Rosa L., et al.: Efficacy of nonionic low-osmolar gadodiamide injection in animals with intracranial mass lesions. JMRI, 1992, 2: 19-25.
15. Oksendal A.N., Hals P.A.: Biodistribution and toxicity of MRI contrast media. JMRI, 1993, 3: 157-166.
16. Chang C.A.: Magnetic resonance imaging contrasts agents design and physicochemical properties of gadodiamide. Invest Radiol, 1993, 28: S21-S27.
17. Chang C.A., Sieving P.F., Watson A.D., et al.: Ionic versus nonionic MRI contrast media: operational definitions. JMRI, 1992, 2: 95-98.
18. Niendorf H.P., Alhassan A., Geens V.R., et al.: Safety review of gadopentate dimeglumine: extended clinical experience after more than 5,000,000 applications. Invest Radiol, 1994, 50: 44-48.